Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Manufacturing
Acuitas takes majority stake in Montreal-based RNA manufacturer
Acuitas Therapeutics shelled out an undisclosed sum to acquire a majority stake in Montreal-based RNA Technologies & Therapeutics.
Joseph Keenan
Jan 8, 2026 9:12am
Sanofi bolsters adult vaccine roster with $2.2B Dynavax purchase
Dec 29, 2025 10:24am
Does the Q4 M&A binge foreshadow a boom year for deals in 2026?
Dec 24, 2025 5:00am
BioMarin makes its largest transaction, paying $4.8B for Amicus
Dec 19, 2025 11:28am
Fosun looks to revive Green Valley's embattled Alzheimer's med
Dec 16, 2025 1:36am
Quvara Medical debuts after group buys Becton Dickinson facility
Dec 4, 2025 9:00am
